Literature DB >> 24801864

Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.

Åsa M Johansson1, Sebastian Ueckert, Elodie L Plan, Andrew C Hooker, Mats O Karlsson.   

Abstract

NONMEM is the most widely used software for population pharmacokinetic (PK)-pharmacodynamic (PD) analyses. The latest version, NONMEM 7 (NM7), includes several sampling-based estimation methods in addition to the classical methods. In this study, performance of the estimation methods available in NM7 was investigated with respect to bias, precision, robustness and runtime for a diverse set of PD models. Simulations of 500 data sets from each PD model were reanalyzed with the available estimation methods to investigate bias and precision. Simulations of 100 data sets were used to investigate robustness by comparing final estimates obtained after estimations starting from the true parameter values and initial estimates randomly generated using the CHAIN feature in NM7. Average estimation time for each algorithm and each model was calculated from the runtimes reported by NM7. The method giving the lowest bias and highest precision across models was importance sampling, closely followed by FOCE/LAPLACE and stochastic approximation expectation-maximization. The methods relative robustness differed between models and no method showed clear superior performance. FOCE/LAPLACE was the method with the shortest runtime for all models, followed by iterative two-stage. The Bayesian Markov Chain Monte Carlo method, used in this study for point estimation, performed worst in all tested metrics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801864     DOI: 10.1007/s10928-014-9359-z

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  12 in total

1.  Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model.

Authors:  Leonid Gibiansky; Ekaterina Gibiansky; Robert Bauer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-11-19       Impact factor: 2.745

2.  Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.

Authors:  Elodie L Plan; Alan Maloney; France Mentré; Mats O Karlsson; Julie Bertrand
Journal:  AAPS J       Date:  2012-04-14       Impact factor: 4.009

3.  Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.

Authors:  Siv Jönsson; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-08       Impact factor: 2.745

4.  Analysis of population pharmacokinetic data using NONMEM and WinBUGS.

Authors:  Stephen B Duffull; Carl M J Kirkpatrick; Bruce Green; Nicholas H G Holford
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

5.  PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Authors:  Lars Lindbom; Pontus Pihlgren; E Niclas Jonsson; Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2005-09       Impact factor: 5.428

Review 6.  A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.

Authors:  Robert J Bauer; Serge Guzy; Chee Ng
Journal:  AAPS J       Date:  2007-03-02       Impact factor: 4.009

7.  Performance in population models for count data, part II: a new SAEM algorithm.

Authors:  Radojka Savic; Marc Lavielle
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-13       Impact factor: 2.745

8.  Performance of three estimation methods in repeated time-to-event modeling.

Authors:  Kristin E Karlsson; Elodie L Plan; Mats O Karlsson
Journal:  AAPS J       Date:  2011-01-13       Impact factor: 4.009

9.  Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.

Authors:  J L Steimer; A Mallet; J L Golmard; J F Boisvieux
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

10.  Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure.

Authors:  L Brynne; J L McNay; H G Schaefer; K Swedberg; C G Wiltse; M O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

View more
  8 in total

1.  Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM® Across Rich, Medium, and Sparse Sampling Data.

Authors:  Waroonrat Sukarnjanaset; Thitima Wattanavijitkul; Sutep Jarurattanasirikul
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

2.  Evaluation of estimation, prediction and inference for autocorrelated latent variable modeling of binary data-a simulation study.

Authors:  Matthew M Hutmacher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-03-23       Impact factor: 2.745

3.  Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.

Authors:  Xiaoxi Liu; Yuhuan Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-05-23       Impact factor: 2.745

4.  Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.

Authors:  Thanh Bach; Guohua An
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-04-21       Impact factor: 2.745

5.  Using sensitivity equations for computing gradients of the FOCE and FOCEI approximations to the population likelihood.

Authors:  Joachim Almquist; Jacob Leander; Mats Jirstrand
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-03-24       Impact factor: 2.745

6.  Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis.

Authors:  T Sahota; A Berges; S Barton; L Cookson; S Zamuner; D Richards
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-02-04

7.  Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.

Authors:  Sudeep Pradhan; Byungjeong Song; Jaeyeon Lee; Jung-Woo Chae; Kyung Im Kim; Hyun-Moon Back; Nayoung Han; Kwang-Il Kwon; Hwi-Yeol Yun
Journal:  BMC Med Res Methodol       Date:  2017-12-01       Impact factor: 4.615

8.  A machine learning approach to personalized dose adjustment of lamotrigine using noninvasive clinical parameters.

Authors:  Xiuqing Zhu; Wencan Huang; Haoyang Lu; Zhanzhang Wang; Xiaojia Ni; Jinqing Hu; Shuhua Deng; Yaqian Tan; Lu Li; Ming Zhang; Chang Qiu; Yayan Luo; Hongzhen Chen; Shanqing Huang; Tao Xiao; Dewei Shang; Yuguan Wen
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.